Immunization
Studies from P. Castro and colleagues yield new information about immunization
Published in Vaccine Weekly, February 10th, 2010
"In addition, VL rebounds could increase HIV-specific immune responses. Twenty-six successfully treated HIV-infected adults were randomized to receive a vaccination schedule or placebo during 12 months. Afterward, HAART was discontinued. Influences of vaccination over VL, genotypic mutations, different T cell subsets, and HIV-1-specific immune responses were evaluated. did not present any secondary effect. No differences in incidence of detectable VL determinations were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-02-10)
More Articles from Vaccine Weekly
- Bird Flu
Study findings from Pohang University of Science & Technology provide new insights into bird flu - Echinococcosis
Study findings from Hokkaido University provide new insights into echinococcosis - Falciparum Malaria
New falciparum malaria study findings reported from Radboud University - Flu Vaccines
Study data from Sanofi Pasteur update knowledge of flu vaccines - HIV/AIDS Vaccine
Recent findings from National Institutes of Health highlight research in HIV/AIDS vaccine - Hormones
New hormones data have been reported by M. Moaeenuddin and co-authors - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
